Quality of Life in EarlyStage Hypertrophic Cardiomyopathy: A Secondary Analysis of the VANISH Trial

被引：0
|
作者：
Ireland, Catherine G.
Day, Sharlene
Axelsson, Anna
Russell, Mark W.
Zahka, Kenneth G.
Pereira, Alexandre
Canter, Charles E.
Bach, Richard G.
Wheeler, Matthew T.
Rossano, Joseph W.
Owens, Anjali T.
Bundgaard, Henning
Mestroni, Luisa
Taylor, Matthew R.
Amit, Patel R.
Wilmot, Ivan
Soslow, Jonathan H.
Becker, Jason R.
Orav, Endel J.
Ho, Carolyn Y.
机构：
来源：
CIRCULATION | 2023年 / 148卷
关键词：
Hypertrophic cardiomyopathy; Quality of life; Angiotensin II Receptor Blocker (ARB); Genetics; Cardiopulmonary exercise testing;
D O I：
10.1161/circ.148.suppl_1.12135
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A12135
引用
收藏
页数：4
相关论文
共 50 条
  • [1] Quality of Life and Exercise Capacity in Early Stage and Subclinical Hypertrophic Cardiomyopathy: A Secondary Analysis of the VANISH Trial
    Ireland, Catherine G.
    Burstein, Danielle S.
    Day, Sharlene M.
    Raja, Anna Axelsson
    Russell, Mark W.
    Zahka, Kenneth G.
    Pereira, Alexandre
    Canter, Charles E.
    Bach, Richard G.
    Wheeler, Matthew T.
    Rossano, Joseph W.
    Owens, Anjali T.
    Bundgaard, Henning
    Mestroni, Luisa
    Taylor, Matthew R. G.
    Patel, Amit R.
    Wilmot, Ivan
    Soslow, Jonathan H.
    Becker, Jason R.
    Giverts, Ilya
    Orav, E. John
    Claggett, Brian
    Lin, Kimberly Y.
    Ho, Carolyn Y.
    CIRCULATION-HEART FAILURE, 2024, 17 (08)
  • [2] Quality of Life and Exercise Performance in Low Risk Hypertrophic Cardiomyopathy: VANISH Ancillary Study
    Burstein, Danielle
    Mondal, Antara
    Min, Jungwon
    Faerber, Jen
    Rossano, Joseph W.
    Ho, Carolyn
    Margossian, Renee E.
    Colan, Steven D.
    O'Connor, Matthew J.
    Soslow, Jonathan H.
    Markham, Larry W.
    Disalvo, Thomas
    Lever, Harry M.
    Zahka, Kenneth G.
    Wilmot, Ivan
    Sublett, Juli
    Russell, Mark W.
    Day, Sharlene
    Patel, Amit
    Murphy, Anne M.
    Canter, Charles E.
    Bach, Richard G.
    Mestroni, Luisa
    Taylor, Matthew
    Ashley, Euan A.
    Wheeler, Matthew T.
    Benson, Lee
    Owens, Anjali T.
    Pahl, Elfriede
    Thrush, Philip
    Pereira, Alexandre D.
    Bundgaard, Henning
    Axelsson, Anna
    Lin, Kimberly Y.
    CIRCULATION, 2019, 140
  • [3] The Design of the Valsartan for Attenuating Disease Evolution in Early Sarcomeric Hypertrophic Cardiomyopathy (VANISH) Trial
    Ho, Carolyn Y.
    McMurray, John J. V.
    Cirino, Allison L.
    Colan, Steven D.
    Day, Sharlene M.
    Desai, Akshay S.
    Lipshultz, Steven E.
    MacRae, Callum A.
    Shi, Ling
    Solomon, Scott D.
    Orav, E. John
    Braunwald, Eugene
    AMERICAN HEART JOURNAL, 2017, 187 : 145 - 155
  • [4] Quality of life in outpatients with hypertrophic cardiomyopathy
    Jacquelinet, M.
    Pentiah, A. Duva
    Coisne, A.
    Lapierre, P.
    Hebbar, E.
    Fertin, M.
    Ridon, H.
    Montaigne, D.
    Lamblin, N.
    De Groote, P.
    EUROPEAN JOURNAL OF HEART FAILURE, 2017, 19 : 253 - 253
  • [5] Sleep Quality and Quality of Life in Patients with Hypertrophic Cardiomyopathy
    Pedrosa, Rodrigo P.
    Lima, Sandro G.
    Drager, Luciano F.
    Genta, Pedro R.
    Amaro, Aline C. S.
    Antunes, Murillo O.
    Arteaga, Edmundo
    Mady, Charles
    Lorenzi-Filho, Geraldo
    CARDIOLOGY, 2010, 117 (03) : 200 - 206
  • [6] Valsartan and Cardiac Remodeling in Early-Stage Hypertrophic Cardiomyopathy: The VANISH Trial Cardiac Magnetic Resonance Substudy
    Ostrominski, John
    Claggett, Brian
    Jerosch-Herold, Michael
    Axelsson, Anna
    Day, Sharlene
    Russell, Mark
    Zahka, Kenneth
    Pereira, Alexandre
    Colan, Steven
    Murphy, Anne
    Canter, Charles
    Bach, Richard
    Wheeler, Matthew
    Rossano, Joseph
    Owens, Anjali
    Mestroni, Luisa
    Taylor, Matthew
    Patel, Amit
    Wilmot, Ivan
    Soslow, Jonathan
    Becker, Jason
    Lakdawala, Neal
    Bundgaard, Henning
    Vargas, Jose
    Ho, Carolyn
    CIRCULATION, 2024, 150
  • [7] HYPERTROPHIC CARDIOMYOPATHY SECONDARY TO PHEOCHROMOCYTOMA
    GROLLIER, G
    KLESZCZ, A
    ISELIN, M
    COMMEAU, P
    FAUCHON, G
    EVRARD, C
    FOUCAULT, JP
    POTIER, JC
    COEUR, 1983, 14 (01): : 105 - 109
  • [8] Quality of Life After Septal Myectomy in Obstructive Patients With Hypertrophic Cardiomyopathy: The Spirit-Hcm Trial
    Desai, Milind Y.
    Rader, Albree Tower
    Szpakowski, Natalie
    Mentias, Amgad
    Popovic, Zoran B.
    Bittel, Barbara
    Fava, Agostina M.
    Thamilarasan, Maran
    Lever, Harry
    Wierup, Per
    Smedira, Nicholas G.
    Nissen, Steve
    CIRCULATION, 2021, 144 (25) : E583 - E583
  • [9] Factors Affecting Quality of Life Among Patients With Hypertrophic Cardiomyopathy
    Oh, YiRae
    Hong, Geu-Ru
    Choi, JiYeon
    Chu, Sang Hui
    CIRCULATION, 2022, 146
  • [10] AFFECT-HCM: quality of life and costs in hypertrophic cardiomyopathy
    Schoonvelde, S. A. C.
    Wiethoff, I
    Hirsch, A.
    Knackstedt, C.
    Germans, T.
    Schinkel, A. F. L.
    Sikking, M.
    Van Slegtenhorst, M. A.
    Verhagen, J. M. A.
    De Boer, R. A.
    Evers, S. M. A. A.
    Hiligsmann, M.
    Michels, M.
    EUROPEAN HEART JOURNAL, 2024, 45
12345